GLI1 and basal cell carcinoma: Several types of carcinoma have been reported to have aberrant activation of Gli1, including hepatocellular carcinoma, gastric cancer, lung cancer, breast cancer and basal cell carcinoma, indicating the dysregulation of Gli1 may contribute to malignant biological behavior [14–16].